Skip to main content

Table 1 Distribution of demographics for patients with oligometastatic EGAC

From: Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival

 

Gastric carcinoma (n = 31)

Esophageal carcinoma (n = 17)

Total (n = 48)

Sex

 Female

11 (35%)

4 (23%)

15 (31%)

 Male

20 (64%)

13 (76%)

33 (69%)

 Age in years*

55.1 (33.6–81.1)

58.3 (30.2–80)

56.8 (30.2–81.2)

ASA classification

 ASA 1–2

17 (55%)

12 (70%)

29 (60%)

 ASA 3–4

14 (45%)

5 (29%)

19 (39%)

 BMI in kg/m2*

26.3 (18.0–41.7)

24.5 (20.5–38.1)

25.3 (18.0–41.7)

Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us